PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid Tumors
Public ClinicalTrials.gov record NCT03284723. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1 Dose Escalation Study Evaluating the Safety and Tolerability of PF-06804103 in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive and Negative Solid Tumors
Study identification
- NCT ID
- NCT03284723
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 95 participants
Conditions and interventions
Conditions
Interventions
- PF-06804103 Drug
- PF-06804103 + Palbociclib +Letrozole Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2017
- Primary completion
- Aug 30, 2021
- Completion
- Aug 30, 2021
- Last update posted
- Sep 2, 2024
2017 – 2021
United States locations
- U.S. sites
- 26
- U.S. states
- 6
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner-University Medical Center Tucson | Tucson | Arizona | 85719 | — |
| The University of Arizona Cancer Center - North Campus | Tucson | Arizona | 85719 | — |
| The University of Arizona Cancer Center | Tucson | Arizona | 85724 | — |
| Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute | Los Angeles | California | 90048 | — |
| UCLA Health (main campus) | Los Angeles | California | 90095 | — |
| UCLA Hematology/Oncology | Los Angeles | California | 90095 | — |
| Santa Monica - UCLA Medical Center and Orthopaedic Hospital | Santa Monica | California | 90404 | — |
| UCLA Dept of Medicine - Hematology/Oncology, Santa Monica | Santa Monica | California | 90404 | — |
| UCLA Health, Santa Monica | Santa Monica | California | 90404 | — |
| Northside Hospital Inc.- GCS/Athens | Athens | Georgia | 30606 | — |
| Atlanta Cancer Care - Atlanta | Atlanta | Georgia | 30342 | — |
| Northside Hospital, Inc. - GCS/Northside | Atlanta | Georgia | 30342 | — |
| Northside Hospital | Atlanta | Georgia | 30342 | — |
| Northside Hospital,Inc.-GCS /Blairsville | Blairsville | Georgia | 30512 | — |
| Northside Hospital, Inc. - GCS/Canton | Canton | Georgia | 30114 | — |
| Atlanta Cancer Care - Cumming | Cumming | Georgia | 30041 | — |
| Northside Hospital, Inc.-GCS/Stemmer | Decatur | Georgia | 30033 | — |
| Suburban Hematology-Oncology Associates - Duluth | Duluth | Georgia | 30096 | — |
| Atlanta Cancer Care - Lake Spivey | Jonesboro | Georgia | 30236 | — |
| Suburban Hematology-Oncology Associates- Lawrenceville | Lawrenceville | Georgia | 30046 | — |
| Northside Hospital, Inc. - GCS/Macon | Macon | Georgia | 31217 | — |
| Northside Hospital, Inc. GCS/Kennestone | Marietta | Georgia | 30060 | — |
| Oncology Hematology West, PC dba Nebraska Cancer Specialists | Omaha | Nebraska | 68130 | — |
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| University of Utah, Huntsman Cancer Hospital | Salt Lake City | Utah | 84112 | — |
| University of Utah, Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03284723, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 2, 2024 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03284723 live on ClinicalTrials.gov.